Influenza A (H1N1) 2009 reinfection in Thailand

Journal of Infection and Public Health

Volumn 5, Issue 2, 2012, Pages 211-214

  Trakulsrichai, Satariya ^a   Watcharananan, Siriorn P ^a   Chantratita, Wasun ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Influenza A (H1N1) 2009; Reinfection

Indexed keywords

OSELTAMIVIR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INFLUENZA A (H1N1); MOUTH EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REINFECTION;

ADULT; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; RECURRENCE; THAILAND;

EID: 84860256798     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2011.10.010     Document Type: Article

References (9)

1. Centers for Disease Control and Prevention (CDC) Novel influenza A (H1N1) virus infections among health-care personnel-United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009, 58(June (23)):641-645.
2. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009 Jul 10, 325(5937):197-201.
3. Department of Disease Control, Ministry of Public Health, Thailand. Situations, Policy, Strategy, and Guideline for Prevention and Control of Pandemic Influenza (H1N1) [cited 2009 Dec 30]. Available from: 2009. http://beid.ddc.moph.go.th/eng/images/stories/New%202010/3%20Situation_strategy_30%20Dec%2009.pdf.
4. Perez C.M., Ferres M., Labarca JA Pandemic (H1N1) 2009 Reinfection, Chile. Emerg Infect Dis 2010, 16(1):156-157.
5. Yu X., Tsibane T., McGraw P.A., House F.S., Keefer C.J., Hicar M.D., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455(September (7212)):532-536.
6. Schmolke M, Garcia-Sastre A. Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol. May 6. [Epub ahead of print].
7. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., Shaw M., et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362(May (18)):1708-1719.
8. Giamarellos-Bourboulis E.J., Raftogiannis M., Antonopoulou A., Baziaka F., Koutoukas P., Savva A., et al. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009, 4(12):e8393.
9. Hung I.F., To K.K., Lee C.K., Lin C.K., Chan J.F., Tse H., et al. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis 2010, 51(August 3):274-279.